Hanlexin may be available in the countries listed below.
Ingredient matches for Hanlexin
Triazolam is reported as an ingredient of Hanlexin in the following countries:
- China
International Drug Name Search
Hanlexin may be available in the countries listed below.
Triazolam is reported as an ingredient of Hanlexin in the following countries:
International Drug Name Search
Rec.INN
C01CA16,S01FB03
0066195-31-1
C17-H25-N-O4
307
Cardiac agent
Propanoic acid, 2-methyl-, 4-[2-(methylamino)ethyl]-1,2-phenylene ester
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Permit Spray may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Permit Spray in the following countries:
International Drug Name Search
Rissar may be available in the countries listed below.
Risperidone is reported as an ingredient of Rissar in the following countries:
International Drug Name Search
Flypel may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorpyrifos is reported as an ingredient of Flypel in the following countries:
Cypermethrin is reported as an ingredient of Flypel in the following countries:
International Drug Name Search
In the US, Lomefloxacin (lomefloxacin systemic) is a member of the drug class quinolones and is used to treat Bladder Infection, Bronchitis, Prostatitis, Salmonella Enteric Fever, Salmonella Gastroenteritis, Shigellosis, Transurethral Prostatectomy and Urinary Tract Infection.
US matches:
Rec.INN
J01MA07,S01AX17
0098079-51-7
C17-H19-F2-N3-O3
351
Antibacterial: Gyrase inhibitor
3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Predniderm may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Predniderm in the following countries:
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Predniderm in the following countries:
International Drug Name Search
Erythromycin is reported as an ingredient of Erythro-Rx in the following countries:
International Drug Name Search
In the US, Amiloride (amiloride systemic) is a member of the drug class potassium-sparing diuretics and is used to treat Ascites, Edema, Heart Failure and High Blood Pressure.
US matches:
UK matches:
Rec.INN
C03DB01
0002609-46-3
C6-H8-Cl-N7-O
229
Potassium-sparing diuretic agent
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
MSIW may be available in the countries listed below.
Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of MSIW in the following countries:
International Drug Name Search
Ramipril beta may be available in the countries listed below.
Ramipril is reported as an ingredient of Ramipril beta in the following countries:
International Drug Name Search
Generic Name: pyrithione (Topical route)
pir-i-THYE-one
In the U.S.
Available Dosage Forms:
Therapeutic Class: Dermatological Agent
Chemical Class: Pyrethrums
Pyrithione is used to help control the symptoms of dandruff and seborrheic dermatitis of the scalp.
This medicine is available without a prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Although there is no specific information comparing use of pyrithione in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of pyrithione in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
This section provides information on the proper use of a number of products that contain pyrithione. It may not be specific to Beta Med. Please read with care.
For best results, use this medicine at least 2 times a week or as directed by your doctor.
To use:
Keep this medicine away from the eyes. If you should accidentally get some in your eyes, flush them thoroughly with water.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
If your condition does not get better after regular use of this medicine, or if it gets worse, check with your doctor.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Beta Med Topical side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Funide may be available in the countries listed below.
Terbinafine is reported as an ingredient of Funide in the following countries:
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Funide in the following countries:
International Drug Name Search
Pamidronat-Mepha may be available in the countries listed below.
Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamidronat-Mepha in the following countries:
International Drug Name Search